The treatment of Ta-T1 bladder cancer in the era of worldwide BCG shortage

Minerva Urologica e Nefrologica

Volumn 68, Issue 2, 2016, Pages 192-193

  Brausi, Maurizio ^a   Morselli, Simone ^a  

^a Ramazzini Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DOXORUBICIN; EPIRUBICIN; MITOMYCIN;

BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CYSTECTOMY; HEALTH CARE AVAILABILITY; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LETTER; MAINTENANCE DRUG DOSE; NON MUSCLE INVASIVE BLADDER CANCER; OVERALL SURVIVAL; URINE CYTOLOGY; CARCINOMA, TRANSITIONAL CELL; INTRAVESICAL DRUG ADMINISTRATION; SUPPLY AND DISTRIBUTION; URINARY BLADDER NEOPLASMS; UROLOGIST;

ADMINISTRATION, INTRAVESICAL; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; HUMANS; URINARY BLADDER NEOPLASMS; UROLOGISTS;

EID: 84992206499     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Babjuk M, Böhle A, Burger M, Compérat E, Kaasinen E, Palou J, et al. EAU Guidelines on Non Muscle Invasive Bladder Cancer (Ta, T1 and CIS), Version 2016 [Internet]. Available from: https://uroweb.org/guideline/nonmuscle-invasive-bladder-cancer/[cited 2016 Mar 14].
2. O ddens J, Brausi M, Sylvester R, Bono A, van de Beek C, van Andel G, et al. Final results of an EORTC-GU Cancers Group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance. Eur Urol 2013;63:462-72.
3. Mostafid AH, Palou Redorta J, Sylvester R, Witjes JA. Therapeutic options in high-risk non-muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-Guérin. Eur Urol 2015;67:359-60.
4. Kassouf W. Approach for consideration to address shortage of bacillus Calmette-Guérin (BCG)-Bladder Cancer Canada [Internet]. Available from: https://bladdercancercanada. org/images/uploads/pdf/Approach-to-Address- BCG-Shortage-Sept-11,-2014-.pdf [cited 2016 Mar 14].
5. A genzia Italiana del Farmaco. [AIFA guidelines on BCG shortage] [Internet page in Italian]. Available from: www. agenziafarmaco.gov.it/it/content/informazioni-relativealla-carenza-dei-medicinali-base-di-bacillo-di-calmetteguerin-immucys [cited 2016 Mar 14].